AU2791689A - Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization - Google Patents

Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization

Info

Publication number
AU2791689A
AU2791689A AU27916/89A AU2791689A AU2791689A AU 2791689 A AU2791689 A AU 2791689A AU 27916/89 A AU27916/89 A AU 27916/89A AU 2791689 A AU2791689 A AU 2791689A AU 2791689 A AU2791689 A AU 2791689A
Authority
AU
Australia
Prior art keywords
colistin
tobramycin
amphotericin
atomization
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27916/89A
Inventor
Xavier Labayle
Louis Lefevre-Utile
Nicole Tenaillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDIPRO Sarl
Original Assignee
MEDIPRO Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDIPRO Sarl filed Critical MEDIPRO Sarl
Publication of AU2791689A publication Critical patent/AU2791689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
AU27916/89A 1987-12-03 1988-12-05 Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization Abandoned AU2791689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8716766A FR2624015B1 (en) 1987-12-03 1987-12-03 MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
FR8716766 1987-12-03

Publications (1)

Publication Number Publication Date
AU2791689A true AU2791689A (en) 1989-07-05

Family

ID=9357419

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27916/89A Abandoned AU2791689A (en) 1987-12-03 1988-12-05 Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization

Country Status (4)

Country Link
EP (1) EP0390832A1 (en)
AU (1) AU2791689A (en)
FR (1) FR2624015B1 (en)
WO (1) WO1989005139A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000576A2 (en) * 1994-06-28 1996-01-11 Dr. Zerle Gmbh Novel clinical uses of polyene macrolides
DE4440391C1 (en) * 1994-11-11 1996-05-09 Haider Angelika Use of aminoglycosides for the diagnosis of barrier disorders
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (en) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalation device and nebulizer
BR112012012475B1 (en) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh NEBULIZER
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (en) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
ES2874029T3 (en) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizer
SI3139982T1 (en) 2014-05-07 2022-05-31 Boehringer Ingelheim International Gmbh Nebulizer
EA032850B1 (en) 2014-05-07 2019-07-31 Бёрингер Ингельхайм Интернациональ Гмбх Container, nebulizer and method of making a container

Also Published As

Publication number Publication date
EP0390832A1 (en) 1990-10-10
WO1989005139A1 (en) 1989-06-15
FR2624015A1 (en) 1989-06-09
FR2624015B1 (en) 1990-06-29

Similar Documents

Publication Publication Date Title
AU2791689A (en) Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization
IE870993L (en) Nasal administration compositions.
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
AU6734990A (en) Freeze-dried dosage forms and methods for preparing the same
AU1779488A (en) Polysaccharides and antiviral drugs containing the same as active ingredient
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
AU3063389A (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
AU2614088A (en) Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
AU2624888A (en) Drug comprising the association of polymyxin b, netilmycin and amphotericin b, administered by spraying
AU650261B2 (en) Derivatives of glycinamide, their preparation and medicaments containing them
AU622007B2 (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions
WO1991015512A3 (en) Hiv envelope polypeptides
AU8714091A (en) Combination of hyaluronic acid with medicinal ingredient and production thereof
AU5449590A (en) Anti-hiv drug
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
AU5360890A (en) Substituted azetidinylisothiazolopyridone derivatives, their preparation and their application as medicinal products
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
AU8282187A (en) 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses
AU2738088A (en) Soluble recombinant fce-receptor, the preparation and the use thereof
AU4560096A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them
AU1638488A (en) Organo-metal compositions, preparation and use
AU1884788A (en) Alpha-fluoroketones, their preparation, and intermediates
AU6157190A (en) Substituted n-heterocycles, their preparation and their use